Administration of low molecular weight heparin within two hours before caesarean section increases the risk of wound haematoma

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 8, 2002, Pages 955-957

  Van Wijk, F H ^a   Wolf, H ^a   Piek, J M J ^a   Buller H R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

ARTICLE; CARDIOVASCULAR RISK; CESAREAN SECTION; CONTROLLED STUDY; DELIVERY; FEMALE; HEMATOMA; HEPARINIZATION; HIGH RISK PATIENT; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; WOUND; CHEMICALLY INDUCED DISORDER; POSTOPERATIVE HEMORRHAGE; PREGNANCY; PREOPERATIVE CARE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TIME;

ANTICOAGULANTS; CESAREAN SECTION; FEMALE; HEMATOMA; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LOGISTIC MODELS; POSTOPERATIVE HEMORRHAGE; PREGNANCY; PREOPERATIVE CARE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0036673138     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-0328(02)00029-0     Document Type: Article

References (4)

1. Lindqvist P., Dahlback B., Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 94:1999;595-599.
2. Bonnar J. Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism? Am J Obstet Gynecol. 180:1999;784-791.
3. Report of the RCOG Working Party on Prophylaxis against Thromboembolism in Gynaecology and Obstetrics 1995. 1995;The College, London.
4. Hirsch J., Levine M.N. Low molecular weight heparin: laboratory properties and clinical evaluation. Eur J Surg. 571(Suppl):1994;9-22.